장내 마이크로바이옴과 차세대 프로바이오틱스 연구 현황

국문 초록 (Abstract)

NGS 기술이 발전함에 따라 우리 몸의 생리와 면역조절에 있어서 장내미생물의 중요성이 알려지면서부터 장내미생물군집의 구조를 직접 조절할 수 있는 프로바이오틱스의 중요성 역시 재조명 받고 있다. 인류는 프로바이오틱스를 오랫동안 발효식품 등을 통하여 섭취하였는데, 프로바이오틱스는 식품의 보존성 및 영양성을 높일 뿐 아니라 인체의 건강에 이로운 역할을 한다. 특히 프로바이오틱스의 섭취는 생체 내에서 Treg의 기능을 활성화하여 장내 환경을 개선시켜 유익한 장내미생물의 생육을 도우며, 염증반응, 알러지질환, 자가면역질환 등을 완화시키는 효과가 있다. 특히 프로바이오틱스는 장내 유익균인 Bifidobacterium, Faecalibacterium, Akkermansia 및 Bacteroides 속 미생물의 빈도를 증가시키고, 이들은 단쇄지방산 및 신체에 이로운 대사체 등을 생산한다. 지금까지 프로바이오틱스는 대부분 건강기능식품으로 사용되어 왔으나, 최근 들어 장내 유익균에 대한 기능성이 알려지면서 기존 프로바이오틱스를 포함한 장내 미생물을 이용한 NGPs 개발이 활발히 진행되고 있다. 하지만 NGPs 개발에는 여전히 한계가 존재한다. 아직까지 장내 미생물의 분리, 동정은 일반 세균 배양에 비해 매우 까다롭고, 특별한 배양 기술이 필요하므로 현재까지 NGPs로 활용될 수 있는 장내 미생물은 매우 제한적이다. 또한 기존 프로바이오틱스와는 다르게 NGPs는 의약품처럼 전임상, 독성시험, 약물역학, 3단계의 임상시험을 거쳐야 한다. 하지만 기존 프로바이오틱스의 질병 개선 효과를 뛰어넘어 고형암, 대사질환 및 면역질환의 차세대 치료제로서의 활용가능성이 매우 높기 때문에 앞으로 더 폭넓은 연구가 진행되어야 할 것이다.

다국어 초록 (Multilingual Abstract)

Gut microbiome have recently provided evidence that the gut microbiota are capable of greatly influencing all aspects of physiology and immunology. Although a number of recent studies have shown that probiotics can modulate gut microbiota structure, the mechanism underlying this effect remains to be elucidated. In a disease state, the relative abundances of beneficial gut bacteria are generally reduced, which is restored by constant probiotic supplementation. Oral administration of probiotics improved the disease state by (1) inducing differentiation and function of regulatory T cells, (2) reducing inflammatory response, (3) modulating the gut environment, and (4) increasing the proportions of short-chain fatty acid- or beneficial metabolite-producing gut microbiota including the genera Bifidobacterium, Faecalibacterium, Akkermansia, etc. In this review, current knowledge on how probiotics can influence host’s health by altering gut microbiota structure and on how probiotics and beneficial gut bacteria can be applied as next-generation probiotics will be discussed.

목차 (Table of Contents)

• Abstract
• 서론
• 본론
• 요약
• 참고문헌

참고문헌 (Reference)

1 Hamady ZZ, "Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus" 59 : 461-469, 2010

2 Lim SK, "Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice" 7 : 40040-, 2017

3 Hamady ZZ, "Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1" 17 : 1925-1935, 2011

4 Tsai YT, "Time-dependent persistence of enhanced immune response by a potential probiotic strain Lactobacillus paracasei subsp. paracasei NTU 101" 128 : 219-225, 2008

5 Zhao X, "The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat dietinduced obese mice" 7 : e30696-, 2012

6 Takata K, "The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells" 6 : e27644-, 2011

7 Karimi G, "The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat dietinduced obese rats" 59 : 29273-, 2015

8 Masuda Y, "TLR ligands of Lactobacillus sakei LK-117 isolated from seed mash for brewing sake are potent inducers of IL-12" 112 : 363-368, 2011

9 Jounai K, "Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells" 7 : e32588-, 2012

10 Ulsemer P, "Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6" 62 : 875-887, 2013

11 Iemoli E, "Probiotics reduce gut microbial translocation and improve adult atopic dermatitis" 46 (46): S33-S40, 2012

12 Drago L, "Probiotics reduce gut microbial translocation and improve adult atopic dermatitis" 46 (46): S33-S40, 2012

13 Frossard CP, "Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization" 119 : 952-959, 2007

14 O'Toole PW, "Next-generation probiotics: the spectrum from probiotics to live biotherapeutics" 2 : 17057-, 2017

15 Ji YS, "Modulation of the murine microbiome with a concomitant antiobesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28" 3 : 13-22, 2012

16 Wang J, "Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice" 9 : 1-15, 2015

17 Won TJ, "Modulation of Th1/Th2 balance by Lactobacillus strains isolated from Kimchi via stimulation of macrophage cell line J774A.1 in vitro" 76 : H55-H61, 2011

18 Lee J, "Mixture of two Lactobacillus plantarum strains modulates the gut microbiota structure and regulatory T cell response in diet-induced obese mice" 62 : e1800329-, 2018

19 Moon YJ, "Lipid-lowering effects of Pediococcus acidilactici M76 isolated from Korean traditional makgeolli in high fat diet-induced obese mice" 6 : 1016-1028, 2014

20 Kwon MS, "Lactobacillus sakei WIKIM30 ameliorates atopic dermatitis-like skin lesions by inducing regulatory T cells and altering gut microbiota structure in mice" 9 : 1905-, 2018

21 Ben Salah R, "Lactobacillus plantarum TN8 exhibits protective effects on lipid, hepatic and renal profiles in obese rat" 23 : 55-61, 2013

22 Fu L, "Lactic acid bacteria-specific induction of CD4+Foxp3+ T cells ameliorates shrimp tropomyosin-induced allergic response in mice via suppression of mTOR signaling" 7 : 1987-, 2017

23 Woo TD, "Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain" 60 : 1617-1625, 2011

24 Ulsemer P, "Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFαspecific antibodies in human adults" 7 : 485-500, 2016

25 Hee Jong Woo, "Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum" 대한수의학회 5 (5): 41-48, 2004

26 Wicken AJ, "Immunogenicity of cell wall and plasma membrane components of some oral lactic acid bacteria" 55 : C34-C41, 1976

27 Lee HY, "Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice" 1761 : 736-744, 2006

28 Tanida M, "High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats" 2 : 1-2, 2008

29 Cheon S, "Heat-killed Lactobacillus acidophilus La205 enhances NK cell cytotoxicity through increased granule exocytosis" 136 : 171-176, 2011

30 Ma C, "Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells" 360 : eaan5931-, 2018

31 Routy B, "Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors" 359 : 91-97, 2018

32 de Roock S, "Gut derived lactic acid bacteria induce strain specific CD4+ T cell responses in human PBMC" 30 : 845-851, 2011

33 Kwon HK, "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders" 107 : 2159-2164, 2010

34 Sokol H, "Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients" 105 : 16731-16736, 2008

35 Rossi O, "Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses" 6 : 18507-, 2016

36 Koizumi S, "Essential role of Toll-like receptors for dendritic cell and NK1.1+ celldependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84" 120 : 14-19, 2008

37 Farrar MD, "Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan" 98 : 1191-1197, 2005

38 Kim HJ, "Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4+CD25+Foxp3+ Tregs" 153 : 178-186, 2014

39 Shimbo I, "Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy" 11 : 7520-7524, 2005

40 Everard A, "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity" 110 : 9066-9071, 2013

41 Kim JH, "Cream cheese-derived Lactococcus chungangensis CAU 28 modulates the gut microbiota and alleviates atopic dermatitis in BALB/c mice" 9 : 446-, 2019

42 Mu Q, "Control of lupus nephritis by changes of gut microbiota" 5 : 73-, 2017

43 Sivan A, "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy" 350 : 1084-1089, 2015

44 Verma R, "Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells" 3 : 6975-, 2018

45 Gauffin Cano P, "Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity" 7 : e41079-, 2012

46 Gérard P, "Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces" 73 : 5742-5749, 2007

47 Hatcher GE, "Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria" 76 : 2485-2492, 1993

48 Kang JH, "Antiobesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice" 8 : e54617-, 2013

49 Mazmanian SK, "An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system" 122 : 107-118, 2005

50 Dao MC, "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology" 65 : 426-436, 2016

51 Deng H, "A novel strain of Bacteroides fragilis enhances phagocytosis and polarises M1 macrophages" 6 : 29401-, 2016

52 Kim HJ, "A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus" 21 : 672-675, 2012